Recent Finacing
Recent Raise
Cyrano Therapeutics is a clinical-stage regenerative medicine company developing CYR-064, an intranasal theophylline spray, and conducting a Phase 2 randomized, double-blind, placebo-controlled trial for post-viral smell and taste loss.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
